$0.40
$0.00 (0.00%)
End-of-day quote: 05/17/2024
NYSEAM:AIM
AIM ImmunoTech Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| MRK | Merck | NYSE | Outperform | $131.19 | $130.51 | 0.00% | 11 | $332.28B |
| AZN | AstraZeneca PLC | LSE | Outperform | £121.10 | £165.99 | 0.00% | 16 | £187.73B |
| NOVN | Novartis | SWX | Hold | CHF93.37 | CHF105.00 | 0.00% | 9 | CHF190.51B |
| PFE | Pfizer | NYSE | Outperform | $28.64 | $32.87 | 0.00% | 6 | $162.29B |
| GSK | GSK | LSE | Outperform | £17.75 | £17.30 | 0.00% | 12 | £72.39B |
| BAX | Baxter International Inc | NYSE | Hold | $35.25 | $44.86 | 0.00% | 5 | $17.96B |
| SRPT | Sarepta Therapeutics | NasdaqGS | Outperform | $131.38 | $158.66 | 0.00% | 6 | $12.51B |
| PRGO | Perrigo Co PLC | NYSE | Outperform | $29.83 | $44.75 | 0.00% | 0 | $4.19B |
| MDG1 | Medigene | XTRA | Buy | 1.41€ | 2.68€ | 0.00% | 0 | 37.46€M |
